Clinical Trials Logo

HER-2 Negative Tumor clinical trials

View clinical trials related to HER-2 Negative Tumor.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01548534 Terminated - Clinical trials for Metastatic Breast Cancer

A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer

DHALYA
Start date: February 2012
Phase: Phase 3
Study type: Interventional

The aim of this study is to increase, by DHA-induced chemosensitization, the activity of anticancer chemotherapy in patients with a metastatic advanced breast cancer, by a nutritional approach with marin-derived PolyUnsaturated Fatty Acids (PUFA).